Mabpharm Limited
HKEX:2181.HK
0.305 (HKD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q2 | 2017 Q1 | 2016 Q4 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 21.571 | 21.571 | 22.01 | 22.01 | 13.536 | 13.536 | 14.424 | 14.424 | 0.818 | 0.818 | 40.623 | 40.623 | 0 | 0 | 0 | 0 | 5.268 | 5.268 | 1.77 | 1.77 | 6.88 | 6.88 | 5.084 | 5.084 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 2.863 | 2.863 | 3.099 | 3.099 | 2.161 | 2.161 | 5.527 | 5.527 | 0.004 | 0.004 | 8.384 | 8.384 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 18.708 | 18.708 | 18.911 | 18.911 | 11.375 | 11.375 | 8.897 | 8.897 | 0.814 | 0.814 | 32.239 | 32.239 | 0 | 0 | 0 | 0 | 5.268 | 5.268 | 1.77 | 1.77 | 6.88 | 6.88 | 5.084 | 5.084 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0.867 | 0.867 | 0.859 | 0.859 | 0.84 | 0.84 | 0.617 | 0.617 | 0.995 | 0.995 | 0.794 | 0.794 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 31.842 | 31.842 | 29.764 | 29.764 | 34.958 | 34.958 | 38.995 | 38.995 | 50.059 | 50.059 | 81.728 | 81.728 | 29.795 | 29.795 | 30.414 | 30.414 | 37.743 | 37.743 | 29.352 | 29.352 | 31.331 | 31.331 | 13.161 | 13.161 | 22.246 | 5.408 | 5.408 | 5.408 |
| General & Administrative Expenses
| 28.753 | 28.753 | 23.577 | 23.577 | 21.363 | 21.363 | 23.916 | 23.916 | 23.439 | 23.439 | 21.878 | 21.878 | 17.527 | 17.527 | 15.371 | 15.371 | 17.533 | 17.533 | 13.933 | 13.933 | 13.6 | 13.6 | 5.993 | 5.993 | 8.591 | 1.217 | 1.217 | 1.217 |
| Selling & Marketing Expenses
| 10.94 | 10.94 | 13.523 | 13.523 | 6.475 | 6.475 | 7.632 | 7.632 | 4.712 | 4.712 | 0 | 0 | 0 | 0 | 0 | 0 | 0.003 | 0.003 | 0.009 | 0.009 | 1.114 | 1.114 | 0.359 | 0.359 | 0 | 0 | 0 | 0 |
| SG&A
| 39.587 | 39.587 | 37.419 | 37.419 | 27.896 | 27.896 | 31.548 | 31.548 | 28.15 | 28.15 | 21.878 | 21.878 | 17.527 | 17.527 | 15.371 | 15.371 | 17.535 | 17.535 | 13.941 | 13.941 | 14.713 | 14.713 | 6.351 | 6.351 | 8.591 | 1.217 | 1.217 | 1.217 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -104.876 | -104.876 | -104.876 | 0 | -61.646 | -61.646 | -61.646 | -13.559 | -13.559 | -13.559 |
| Operating Expenses
| 70.912 | 70.912 | 66.672 | 66.672 | 56.407 | 56.407 | 65.871 | 65.871 | 73.993 | 73.993 | 104.707 | 104.707 | 65.206 | 65.206 | 29.869 | 29.869 | 48.7 | 48.7 | 57.717 | 57.717 | 60.389 | 60.389 | 25.697 | 25.697 | -30.809 | -6.934 | -6.934 | -6.934 |
| Operating Income
| -52.721 | -52.721 | -48.272 | -48.272 | -51.479 | -51.479 | -61.647 | -61.647 | -77.395 | -77.395 | -71.367 | -71.367 | -47.322 | -47.322 | -45.785 | -45.785 | -52.074 | -52.074 | -41.523 | -41.523 | -42.667 | -42.667 | -17.179 | -17.179 | -30.809 | -6.934 | -6.934 | -6.934 |
| Operating Income Ratio
| -2.444 | -2.444 | -2.193 | -2.193 | -3.803 | -3.803 | -4.274 | -4.274 | -94.614 | -94.614 | -1.757 | -1.757 | 0 | 0 | 0 | 0 | -9.886 | -9.886 | -23.466 | -23.466 | -6.202 | -6.202 | -3.379 | -3.379 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -1.958 | -1.958 | -1.728 | -1.728 | 4.474 | 4.474 | 3.242 | 3.242 | 4.103 | 4.103 | -1.214 | -1.214 | -17.9 | -17.9 | 18.691 | 18.691 | 8.65 | 8.65 | -16.318 | -16.318 | -12.077 | -12.077 | -4.374 | -4.374 | -7.339 | -4.993 | -4.993 | -4.993 |
| Income Before Tax
| -54.679 | -54.679 | -50 | -50 | -47.005 | -47.005 | -58.405 | -58.405 | -73.292 | -73.292 | -72.581 | -72.581 | -65.222 | -65.222 | -27.094 | -27.094 | -43.424 | -43.424 | -57.841 | -57.841 | -54.744 | -54.744 | -21.553 | -21.553 | -38.148 | -11.927 | -11.927 | -11.927 |
| Income Before Tax Ratio
| -2.535 | -2.535 | -2.272 | -2.272 | -3.473 | -3.473 | -4.049 | -4.049 | -89.598 | -89.598 | -1.787 | -1.787 | 0 | 0 | 0 | 0 | -8.244 | -8.244 | -32.687 | -32.687 | -7.957 | -7.957 | -4.239 | -4.239 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | -0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.924 | 1.924 | 1.417 | 1.417 | -0.709 | -0.709 | -0.709 | 0.832 | 0.832 | 0.832 |
| Net Income
| -54.679 | -54.679 | -50 | -50 | -47.005 | -47.005 | -58.405 | -58.405 | -73.292 | -73.292 | -72.581 | -72.581 | -65.222 | -65.222 | -27.094 | -27.094 | -43.424 | -43.424 | -57.841 | -57.841 | -48.409 | -48.409 | -14.033 | -14.033 | -37.44 | -12.759 | -12.759 | -12.759 |
| Net Income Ratio
| -2.535 | -2.535 | -2.272 | -2.272 | -3.473 | -3.473 | -4.049 | -4.049 | -89.598 | -89.598 | -1.787 | -1.787 | 0 | 0 | 0 | 0 | -8.244 | -8.244 | -32.687 | -32.687 | -7.037 | -7.037 | -2.76 | -2.76 | 0 | 0 | 0 | 0 |
| EPS
| -0.015 | -0.015 | -0.012 | -0.012 | -0.011 | -0.011 | -0.015 | -0.015 | -0.018 | -0.018 | -0.02 | -0.02 | -0.016 | -0.016 | -0.007 | -0.007 | -0.011 | -0.011 | -0.017 | -0.017 | -0.018 | -0.018 | -0.01 | -0.01 | -0.009 | -0.003 | -0.003 | -0.003 |
| EPS Diluted
| -0.013 | -0.013 | -0.012 | -0.012 | -0.011 | -0.011 | -0.014 | -0.014 | -0.018 | -0.018 | -0.018 | -0.018 | -0.016 | -0.016 | -0.007 | -0.007 | -0.011 | -0.011 | -0.017 | -0.017 | -0.016 | -0.016 | -0.01 | -0.01 | -0.009 | -0.003 | -0.003 | -0.003 |
| EBITDA
| -38.549 | -38.549 | -36.515 | -36.515 | -40.682 | -40.682 | -51.157 | -51.157 | -67.067 | -67.067 | -64.324 | -64.324 | -43.055 | -43.055 | -41.912 | -41.912 | -48.372 | -48.372 | -37.952 | -37.952 | -39.04 | -39.04 | -14.948 | -14.948 | -27.88 | -4.414 | -4.414 | -4.414 |
| EBITDA Ratio
| -1.787 | -1.787 | -1.659 | -1.659 | -3.006 | -3.006 | -3.547 | -3.547 | -81.99 | -81.99 | -1.583 | -1.583 | 0 | 0 | 0 | 0 | -9.183 | -9.183 | -21.448 | -21.448 | -5.675 | -5.675 | -2.94 | -2.94 | 0 | 0 | 0 | 0 |